Mutational interactions define novel cancer subgroups
Tumour heterogeneity hinders translation of large-scale genomic data into the clinic. Here the authors develop a method for the stratification of cancer patients based on the molecular gene status, including genetic interactions, rather than clinico-histological data, and apply it to TCGA data for over 8000 cases across 22 cancer types.
Introduction The past years have seen great progress towards a deeper understanding of the molecular changes underpinning cancer progression. Identification and characterisation of molecular subtypes within and across different cancer types has emerged as a promising approach for the development of targeted therapies1,2,3. Nevertheless, cancer treatment is far from optimal. The approval of the limited number of available cancer drugs is often limited to a specific cancer type or subtype, preventing widespread use of targeted therapies. Moreover, cancers may develop resistance against these…
saved by
related reading
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance - PMCncbi.nlm.nih.gov
- Epigenetic regulation during cancer transitions across 11 tumour typesnature.com
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Pancreatic Cancer - PMCncbi.nlm.nih.gov
- A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen - PMCpmc.ncbi.nlm.nih.gov
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
- Clustering analysis of tumor metabolic networks | BMC Bioinformatics | Springer Nature Linkbmcbioinformatics.biomedcentral.com
- Has pancreatic cancer met its match?worksinprogress.co
- A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damagenature.com
- A practical guide for mutational signature analysis in hematological malignancies | Nature Communicationsnature.com
- A simple algebraic cancer equation: calculating how cancers may arise with normal mutation ratesbmccancer.biomedcentral.com
- Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data | eLifeelifesciences.org